太陽紙業(002078.SZ)擬回購註銷36.6萬限制性股票
格隆匯11月15日丨太陽紙業(002078.SZ)公佈,公司限制性股票激勵計劃(2017—2019)激勵對象牛成對等8人因個人原因離職,不再滿足成為激勵對象的條件。根據《公司限制性股票激勵計劃(2017—2019)》以及相關法律、法規的有關規定,上述8人所持已獲授但尚未解除限售的36.6萬限制性股票由公司回購註銷,佔公司目前總股本的0.0141%。回購價格調整為4.45元/股,本次回購金額合計為162.87萬元,回購資金為公司自有資金。
本次回購註銷部分限制性股票將導致公司註冊資本減少36.6萬元,本次回購註銷完成後,公司註冊資本將由人民幣2,591,554,335元調整為2,591,188,335元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.